|[March 30, 2011]
Breakthrough CardioHealth® Station Cleared By FDA To Take Center Stage At The Annual Scientific Sessions Of The American College Of Cardiology 2011
HOUSTON --(Business Wire)--
CardioNexus Corporation (www.cardionexus.com)
an affiliated company of Panasonic (News - Alert) Healthcare Co. Ltd., will introduce
Panasonic CardioHealth® Station at the 2011 Annual Scientific Sessions
of the American College of Cardiology. The device, which has just
received clearance from the U.S. Food & Drug Administration, is an
automated and portable cardiovascular imaging device which aims to
complement traditional blood pressure and cholesterol measurement in
physicians' offices and to help detect the hidden risk of heart attack
The FDA decision allows Houston-based CardioNexus to sell the
CardioHealth® Station for use not only in hospitals and community
clinics, but also in cardiologist, internist and family physician
offices, as well as in retail healthcare clinics.
The device, which relies on Panasonic's advanced, high-resolution,
real-time, ultrasound technology, measures the thickness of the arterial
wall through the skin quickly and reproducibly. It is considered a major
advancement in the automation of medical technologies which enable
physicians, their assistants, and nurse practitioners who are not
specialized in ultrasound imaging to use the device and detect High Risk
"The CardioHealth® report which combines Framingham Risk Score with
carotid IMT and plaque assessment provides a more accurate assessment of
a patient's risk than measuring blood pressure and cholesterol alone,"
says Dr. Morteza Naghavi, President and CEO of CardioNexus Corporation.
"It takes us beyond the status quo and empowers internists and primary
care physicians to use noninvasive imaging in their office."
According to a 2010 study based on the American Heart Association's "Get
With The Guidelines" initiative, only 23% of 136,905 patients
hospitalized with coronary artery disease had high LDL, or "bad
cholesterol" levels while 77% were reported to have normal LDL levels
and therefore would not have been identified as High Risk.
The noninvasive imaging feature of CardioHealth® Station represents a
breakthrough introduction into the primary healthcare markt by the
collaborative effort of CardioNexus and Panasonic Healthcare since their
partnership was announced last October. Other features, such as
Point-of-Care genetic testing for monitoring response to drug therapies,
which collectively aim at Personalized Preventive Medicine will be
introduced in the future.
"We've already seen tremendous interest in the technology, particularly
among internists and primary care physicians who up until now have not
had an automated non-invasive imaging technology in their office," says
Steven Lynum, Director of Panasonic Healthcare's Clinical Products who
is also an Executive Vice President at CardioNexus. "CardioHealth®
Station allows them to easily incorporate atherosclerosis imaging in
their management of cardiovascular patients based on the recent
The CardioHealth Station includes a handheld ultrasound probe to scan
the carotid arteries on both sides of the neck and to detect hidden
plaque build up and increased thickness in the artery wall. Testing is
performed in a matter of minutes without pain, discomfort or exposure to
radiation; and the results are available immediately.
According to the American Heart Association there are over 60 million
Americans at risk of a heart attack and in need of screening and
"We are proud that Houston's CardioNexus in partnership with the world's
largest consumer electronics manufacture, Panasonic Corporation, is
introducing breakthrough medical technologies," said Leo Womack, a well
known Houston life science investor who chairs CardioNexus' Board of
Directors. "Texas needs more of these CardioNexus type initiatives."
For details and to view a demonstration video, visit www.cardionexus.com.
About CardioNexus Corporation
CardioNexus Corporation is an affiliated company of Panasonic Healthcare
dedicated to reducing cardiovascular disease through early detection and
prevention. CardioNexus' flagship product, the CardioHealth® Station, is
a new multi-modality initiative to advance cardiovascular health
assessment for the prevention of heart attack and stroke. The advanced,
automated features of the CardioHealth® Station enable physicians,
especially primary care physicians and internists, to perform
atherosclerosis imaging and cardiovascular risk assessment in their
offices, without need for outside referral.
Based in Secaucus, NJ, Panasonic Corporation of North America provides a
broad line of digital and other electronics products for consumer,
business and industrial use. The company is the principal North American
subsidiary of Panasonic Corporation (NYSE: PC), and the hub of
Panasonic's U.S. branding, marketing, sales, service and R&D operations.
Panasonic Corporation of North America's newly formed Healthcare Group
brings together Panasonic's expertise in a wide range of health and
medical device technologies, including hearing care. For more
information visit www.panasonic.com/hearing.
Additional Panasonic information for journalists is available at www.panasonic.com/pressroom.
About Panasonic Healthcare Co., Ltd.
Panasonic Healthcare Co., Ltd., headquartered in Matsuyama, Japan, is an
internal division company of Panasonic Corporation (NYSE: PC) that
specializes in the development and manufacture of healthcare products,
including blood glucose monitoring systems, ultrasound diagnostic
systems and hearing instruments. Founded in 1948, the company has been
developing cutting-edge technologies in in-vitro diagnostic systems,
medical imaging, hearing solutions, medical instruments and hospital
systems to provide value-added solutions to healthcare professionals and
patients. The previous corporate name was Panasonic Shikoku Electronics
Co., Ltd., which was changed to the current Panasonic Healthcare Co.,
Ltd. on October 1, 2010.
[ Back To TMCnet.com's Homepage ]